John M. Talmadge, M.D., on Using Benzodiazepines in Substance Abusers
The Carlat Psychiatry Report, Volume 3, Number 9, September 2005
John M. Talmadge, M.D.
Director, Addiction Psychiatry Fellowship Training Program
Associate Professor of Psychiatry
University of Texas Southwestern Medical Center
Dr. Talmadge has disclosed that, in the past 12 months, he has been a member of the speakers bureaus for Astra-Zeneca, Eli Lilly, Forest Pharmaceuticals, and Janssen. He has no current industry relationships to disclose. The editors of The Carlat Report have closely reviewed the content of Dr. Talmadge’s interview and have determined that there are no financial conflicts of interest regarding this educational activity.
Dr. Talmadge, in your practice, do you ever prescribe benzodiazepines to people with substance abuse histories?